Wistar Rabies Virus Strain PM-1503-3M Vaccine clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses Wistar Rabies Virus Strain PM-1503-3M Vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Sanofi Pasteur, a Sanofi Company (2) · Fred Hutchinson Cancer Center (1)
Studies
Open first, then newest update. How each study uses Wistar Rabies Virus Strain PM-1503-3M Vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Vaccine Responsiveness After CAR-T Cell TherapyCompletedPhase 1Fred Hutchinson Cancer CenterNCT04410900Written as Wistar Rabies Virus Strain PM-1503-3M Vaccine
- Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure UseCompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT01784874Written as Imovax® Rabies: inactivated rabies vaccine
- Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure RegimenCompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT01877395Written as Imovax® Rabies: inactivated rabies vaccine
As the comparator · 3 — what is tested is compared with Wistar Rabies Virus Strain PM-1503-3M Vaccine
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in AdultsCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT03965962Written as Human Diploid Cell Vaccine (HDCV)
- Immunogenicity and Safety of a Purified Vero Rabies VaccineCompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT03145766Written as Imovax Rabies
- Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis RegimenCompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT01930357Written as Imovax® Rabies: Human Diploid Cell Vaccine (HDCV),